<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Venaxis Inc - Google Finance</title>
<description>News for Venaxis Inc - Google Finance</description>
<link>http://www.google.ca/finance?q=NASDAQ:APPY&amp;amp;client=news-rss&amp;amp;ei=pTueUciaGfDq0QHTJw</link>
<image>
<title>News for Venaxis Inc - Google Finance</title>
<url>/finance/s/HeRQIg9C9Us/images/logo_ca.gif</url>
<link>http://www.google.ca/finance?q=NASDAQ:APPY&amp;amp;client=news-rss&amp;amp;ei=pTueUciaGfDq0QHTJw</link>
</image>
<item>
<title>This Metric Says You Are Smart to Buy Palatin Technologies, Inc. (PTN)</title>
<link>http://www.insidermonkey.com/blog/this-metric-says-you-are-smart-to-buy-palatin-technologies-inc-ptn-129181/</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:http://www.insidermonkey.com/blog/this-metric-says-you-are-smart-to-buy-palatin-technologies-inc-ptn-129181/</guid>
<pubDate>Sun, 28 Apr 2013 17:22:41 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/this-metric-says-you-are-smart-to-buy-palatin-technologies-inc-ptn-129181/&quot; style=&quot;font-size:1.2em&quot;&gt;This Metric Says You Are Smart to Buy Palatin Technologies, Inc. (PTN)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 28, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Let&amp;#39;s also review hedge fund and insider activity in other stocks similar to Palatin Technologies, Inc. (NYSEAMEX:PTN). These stocks are Rosetta Genomics Ltd.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Venaxis Inc Receives Purchase Order From EMELCA Bioscience</title>
<link>http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2689542</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:2689542</guid>
<pubDate>Thu, 07 Feb 2013 12:30:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2689542&quot; style=&quot;font-size:1.2em&quot;&gt;Venaxis Inc Receives Purchase Order From EMELCA Bioscience&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Feb 7, 2013 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Venaxis Inc Initiates Patient Enrollment For APPY1 Pivotal Study</title>
<link>http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2674527</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:2674527</guid>
<pubDate>Tue, 15 Jan 2013 12:30:15 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2674527&quot; style=&quot;font-size:1.2em&quot;&gt;Venaxis Inc Initiates Patient Enrollment For APPY1 Pivotal Study&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Jan 15, 2013 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Venaxis Inc Files For CE Mark Approval</title>
<link>http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2664918</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:2664918</guid>
<pubDate>Fri, 21 Dec 2012 12:30:06 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2664918&quot; style=&quot;font-size:1.2em&quot;&gt;Venaxis Inc Files For CE Mark Approval&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Dec 21, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Venaxis, Inc. Announces Full Exercise Of Underwriter&amp;#39;s Over-Allotment Option</title>
<link>http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2663835</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:2663835</guid>
<pubDate>Wed, 12 Dec 2012 00:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2663835&quot; style=&quot;font-size:1.2em&quot;&gt;Venaxis, Inc. Announces Full Exercise Of Underwriter&amp;#39;s Over-Allotment Option&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Dec 12, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>AspenBio Pharma Inc Changes Company Name To Venaxis, Inc.</title>
<link>http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2663833</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:2663833</guid>
<pubDate>Wed, 12 Dec 2012 00:00:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2663833&quot; style=&quot;font-size:1.2em&quot;&gt;AspenBio Pharma Inc Changes Company Name To Venaxis, Inc.&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Dec 12, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>AspenBio Pharma Inc Announces Closing Of Public Offering Of 1,946,000 Shares Of Common Stock</title>
<link>http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2646434</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:2646434</guid>
<pubDate>Tue, 20 Nov 2012 21:20:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2646434&quot; style=&quot;font-size:1.2em&quot;&gt;AspenBio Pharma Inc Announces Closing Of Public Offering Of 1,946,000 Shares Of Common Stock&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Nov 20, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>AspenBio Pharma Inc Announces Pricing of Public Offering of 1,476,000 Shares of Common Stock</title>
<link>http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2643656</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:2643656</guid>
<pubDate>Thu, 15 Nov 2012 01:55:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2643656&quot; style=&quot;font-size:1.2em&quot;&gt;AspenBio Pharma Inc Announces Pricing of Public Offering of 1,476,000 Shares of Common Stock&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Nov 15, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>AspenBio Pharma Inc Announces Proposed Public Offering</title>
<link>http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2643587</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:2643587</guid>
<pubDate>Wed, 14 Nov 2012 21:41:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2643587&quot; style=&quot;font-size:1.2em&quot;&gt;AspenBio Pharma Inc Announces Proposed Public Offering&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Nov 14, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>AspenBio Pharma Inc Proposes Corporate Name Change To Venaxis, Inc</title>
<link>http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2622940</link>
<guid isPermaLink="false">tag:finance.google.ca,cluster:2622940</guid>
<pubDate>Mon, 15 Oct 2012 11:30:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/finance/stocks/APPY.O/key-developments/article/2622940&quot; style=&quot;font-size:1.2em&quot;&gt;AspenBio Pharma Inc Proposes Corporate Name Change To Venaxis, Inc&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters Key Development&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Oct 15, 2012 &lt;/span&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
